Device Trial Radar · NCT01383018
PROPPER Prospective Registry of Outcomes With Penile Prosthesis
Last checked: Nov 20, 2026Latest source record: Feb 12, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,457
Actual
Start
Jun 13, 2011
Primary completion
Nov 30, 2017
Study completion Jul 25, 2018
Sponsor
- Lead sponsor
- Boston Scientific CorporationPublic (BSX)
- Sponsor type
- Industry
- First posted
- Jun 28, 2011
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this observational registry is to collect and better understand "real-world" outcomes for men undergoing penile implant surgery to treat erectile dysfunction.
Conditions
- Erectile Dysfunction
- Impotence
Interventions
AMS Penile Prosthesis DevicesDevice
Non-interventional device registry. Outcomes for patients receiving marketed AMS penile prosthesis devices.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Penile Prosthesis Overall Subject SatisfactionTime frame: 1 year, post-implantation
- Number of Participants With Penile Prosthesis That Are Using the DeviceTime frame: 1 year, post implantation
- Number of Participants With Penile Prosthesis That Are Using the Device Indicating How Often Their Use is.Time frame: 1 year, post implantation
4 more outcomes with a free account
Locations
11 sites in 2 countries. Site status is shown where the registry gives one.
Urology Centers of Alabama
Homewood, Alabama
El Camino Urology Medical Group
Mountain View, California
Kaiser Permanente
San Diego, California
8 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.